OncoZenge AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	89	85	44	36	64	135
Market Cap Growth	49.62%	94.64%	21.36%	-43.82%	-52.42%	-
Enterprise Value	93	81	38	20	32	80
Last Close Price	6.35	6.76	3.75	3.09	5.50	11.56
PS Ratio	32.04	30.71	43924.67	12064.64	-	-
PB Ratio	10.52	10.09	4.42	1.94	1.90	1.69
P/TBV Ratio	54.83	52.55	14.17	3.07	2.38	1.84
EV/Sales Ratio	33.40	29.24	38094.67	6750.97	-	-
EV/EBITDA Ratio	-	-	-	2.79	11.43	-
Debt / Equity Ratio	0.89	0.89	-	-	-	-
Net Debt / Equity Ratio	0.45	0.45	-0.39	-0.68	-0.86	-0.64
Net Debt / EBITDA Ratio	-	-	-	-1.74	-10.53	-
Asset Turnover	0.16	0.16	0	0	-	-
Quick Ratio	0.74	0.74	2.95	7.81	10.22	10.62
Current Ratio	1.01	1.01	3.09	7.94	10.29	10.63
Return on Equity (ROE)	-173.01%	-173.01%	-60.77%	-60.45%	-81.62%	-7.09%
Return on Assets (ROA)	-55.07%	-55.07%	-34.17%	-34.73%	-20.88%	-4.95%
Return on Capital Employed (ROCE)	-98.80%	-98.80%	-87.30%	-85.30%	-60.10%	-6.10%
Earnings Yield	-17.87%	-18.64%	-19.78%	-43.94%	-72.41%	-2.87%
Buyback Yield / Dilution	-7.97%	-7.97%	-	-	0.53%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.